Wednesday, 18 September 2019

Japan News

  • Another Japanese university finds data manipulation for Novartis drug

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 31 Jul, 2013

    Singapore: The Jikei University School of Medicine has become the second Japanese university to find that clinical data had been manipulated for a Novartis Pharma drug that lowers blood pre...Read more

  • Prism to start PRI-724 trials to treat fibrosis

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 14 Jun, 2013

    Singapore: Prism Pharma, a drug discovery company focused on developing small molecule technologies that modulate protein-protein interactions, announced the close of an approximately $15 m...Read more

  • Takeshi Yura is AMRI Asia discovery VP

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 26 Feb, 2013

    Singapore: Dr Takeshi Yura has been promoted by AMRI to the position of vice president of discovery and development services, Asia. Dr Yura will report directly to Dr Thomas E. D'Ambra, cha...Read more

  • APAC stem cell therapy market to reach $972mn in 2018

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 01 Jan, 2013

    Singapore: A new study by Reports and Reports predicted that the stem cell therapy market in Asia Pacific (APAC) will grow in value from $545 million in 2012 to $972 million in 2018, at a c...Read more

  • Medtronic starts trial of renal denervation system in Japan

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 02 Oct, 2012

    Singapore: Medtronic started Symplicity HTN-Japan, the first clinical trial with the Symplicity renal denervation system in Japan for patients with treatment-resistant hypertension. The cli...Read more

  • BMS-Pfizer stroke drug gets Japanese nod

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 27 Dec, 2012

    Singapore: Bristol-Myers Squibb and Pfizer announced that the Japanese Ministry of Health, Labor and Welfare (MHLW) has approved Eliquis (apixaban) for the prevention of ischemic stroke an...Read more

  • Chugai gets Japanese nod cancer drug Kadcyla

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 23 Sep, 2013

    Singapore: The Japanese Ministry of Health, Labour and Welfare has approved Oncology specializing pharmaceutical firm Chugai Pharmaceutical's anti-cancer agent Kadcyla, for HER2-positive in...Read more

  • Biosensors to collaborate with Terumo in Japan

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 08 Feb, 2013

    Singapore: Biosensors International, a developer, manufacturer and marketer of innovative medical devices, is collaborating with Japanese company Terumo to promote the Nobori drug-eluting s...Read more

  • Nexavar seeks marketing authorization in Japan

    Japan |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 01 Oct, 2013

    Singapore: Bayer HealthCare has submitted an additional application for marketing authorization to the Ministry of Health, Labour and Welfare (MHLW) in Japan for Nexavar (Sorafenib) tablets...Read more

  • Shinogi starts supply of Pirespa to Ildong

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 16 Oct, 2012

    Singapore: Osaka-based Shionogi has began to supply Pirespa 200mg tablet (pirfenidone) to Ildong Pharmaceutical, which is headquartered in Seoul, for the treatment of idiopathic pulmonary f...Read more

  • US-based TriReme looks for big growth in Asia

    Japan |  Influencers | By BioSpectrum Bureau  | 0 Comment | 31 May, 2012

    TriReme Medical, a US-based start-up medical devices company dedicated to the development and manufacturing of innovative devices for the treatment of complex vascular disease, recently ope...Read more

  • Abbott and Sucampo get nod for AMITIZA in Japan

    Japan |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 09 Jul, 2012

    Singapore: Sucampo Pharma and Abbott received approval from the Ministry of Health, Labor and Welfare, Japan for AMITIZA (lubiprostone). The drug is a prescription medicine that is used for...Read more

  • Otsuka launches English website for global viewers

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 02 Aug, 2013

    Singapore: Japan-based Otsuka Pharmaceutical launched a newly designed English corporate website in collaboration with an Amsterdam-based creative agency. The new site reflects Otsuka's phi...Read more

  • Takeda diabetes drug gets China's import license

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 06 Aug, 2013

    Singapore: China's State Food and Drug Administration (SFDA) issued an Import Drug License (IDL) for Takeda's type 2 diabetes drug Nesina (alogliptin). Orally administered dipeptidyl pept...Read more

  • Japan Minister: Dont be afraid of new science strategy

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 26 Jun, 2013

    Singapore: Japanese scientists are skeptical about the country's new strategy for economic growth, which includes an emphasis on applied biomedical research. Several life science organizati...Read more

  • Takeda appoints first-ever non-Japanese president

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 02 Dec, 2013

    Singapore: In an effort to speedup business expansion in emerging nations, Japan's largest drug maker, Takeda Pharmaceuticals has chosen its new president from a rival company. The company...Read more

  • FDA panel approves new obesity drug, Eisai to market it

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 14 May, 2012

    Cambridge, Massachusetts: Lorcaserin, a chemical drug that aims to control obesity by altering the serotonin receptors in the brain that control hunger pangs, developed by Arena Pharmaceuti...Read more

  • Japan pharma to grow at 2% CAGR from 2013-20

    Japan |  Analysis | By BioSpectrum Bureau  | 0 Comment | 11 Jul, 2013

    Singapore: Simplification of the regulatory process will prove to be the key to the growth of the pharma market in Japan, claimed a recent report by Research and Markets. The CountryFocus ...Read more



Podcast

 

Survey Box

Is Pharma innovation getting inhibited in APAC?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls